Incidence, predictors and clinical outcome of early bleeding events in patients undergoing a left ventricular assist device implant
- 22 February 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 54 (1), 176-182
- https://doi.org/10.1093/ejcts/ezy044
Abstract
Bleeding is a common complication following left ventricular assist device (LVAD) implantation. The goal of this study was to investigate the incidence, predictors and clinical outcome of early bleeding events in patients after LVAD implantation. A total of 83 patients (age 50 ± 13 years, 76% men) had an LVAD implanted [77% HeartMate II, 19% HeartMate 3 (Abbott, Chicago, IL, USA)] over a period of 11 years. Patients were included consecutively. An early bleeding event was defined as the need for thoracic surgical re-exploration or transfusion with >4 units of packed red blood cells before discharge. Overall, 39 (47%) patients (age 50 ± 14 years, 77% men) experienced an early bleeding event [median time 6 days (interquartile range 1–9 days)]. Furthermore, 10 (26%) of these patients had ≥2 bleeding events. Twelve of the 14 (92%) patients with venoarterial extracorporeal membrane oxygenation (ECMO) support before LVAD implantation experienced an early bleeding event versus 27 of the 69 (39%) patients without ECMO support (P < 0.001). No difference was found in early bleeding rates between HeartMate II and HeartMate 3. Predictors for early bleeding events were lower pre- and postimplant platelet counts and ECMO support preimplantation. After multivariable adjustment, early bleeding events were associated with ECMO support preimplantation (odds ratio 6.3, 95% confidence interval 1.2–32.4; P = 0.03) and thrombocytopenia (9/l) postimplant (odds ratio 5.9, 95% confidence interval 1.9–18.7; P = 0.002). Patients who experienced an early bleeding event had a significantly worse 90-day survival rate compared to patients who did not (79% vs 96%, P = 0.03). An early bleeding event needing surgical exploration is highly prevalent after LVAD implantation, especially in patients bridged with ECMO and with pre- and postimplant thrombocytopenia.Keywords
Funding Information
- NWO
- Netherlands Organisation for Scientific Research
This publication has 22 references indexed in Scilit:
- Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patientsJournal of Surgical Research, 2016
- Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate IINetherlands Heart Journal, 2015
- Coagulopathy in Mechanical Circulatory Support: A Fine BalanceCurrent Cardiology Reports, 2015
- Seventh INTERMACS annual report: 15,000 patients and countingThe Journal of Heart and Lung Transplantation, 2015
- Early Diagnosis of Acquired von Willebrand Syndrome (AVWS) is Elementary for Clinical Practice in Patients Treated with ECMO TherapyJournal of Atherosclerosis and Thrombosis, 2015
- Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patientsEuropean Journal of Cardio-Thoracic Surgery, 2011
- Early adverse events as predictors of 1-year mortality during mechanical circulatory supportThe Journal of Heart and Lung Transplantation, 2010
- Extracorporeal membrane oxygenation bridge to adult heart transplantationClinical Transplantation, 2010
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceThe New England Journal of Medicine, 2009
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationThe New England Journal of Medicine, 2007